@prefix this: <http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik> .
@prefix sub: <http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   <http://purl.obolibrary.org/obo/DOID_10763> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_10763> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB00701> ;
    a rdf:Statement ;
    rdfs:label "\"*     [see Drug Interactions ( 7 12.3      * LEXIVA is contraindicated when coadministered with the following drugs:  o Alpha 1-adrenoreceptor antagonist: Alfuzosin  o Antiarrhythmics: Flecainide (with ritonavir), propafenone (with ritonavir)  o Antimycobacterial: Rifampin  o Antipsychotic: Lurasidone (with ritonavir), pimozide  o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine  o GI motility agent: Cisapride  o Herbal product: St. John's wort ( Hypericum perforatum    o Lipid modifying agents: Lomitapide, lovastatin, simvastatin  o Non-nucleoside reverse transcriptase inhibitor: Delavirdine  o PDE5 inhibitor: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension)  o Sedative/hypnotics: Midazolam, triazolam     * 4   * 4   * 4\"" ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:MedicalContraindication .
  <https://identifiers.org/drugbank:DB00701> bl:category bl:Drug .
}
sub:provenance {
   sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "KbmORKHgOhdE4yYyClv95x8Ra0oBPSaXPdTeZSYXns62laEFVYQX9M+SArGkgBvk9+wS/lBE2zfQuRRy+6/B8wOuW02F/U6FEJ1IlLlqWoxxK6Qiz3digzHoCV17AExW38CW827p/CluSJpEd9FwzxM2z5c30UxA8/kS9PpRp6k=" ;
    npx:hasSignatureTarget this: .
  this: dct:created "2021-08-23T18:36:07.853+02:00"^^xsd:dateTime ;
    dct:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}